Form 4: Moderna CFO James Mock Reports Stock Transactions

Chief Financial Officer of Moderna, James Mock, reports the acquisition and disposal of company stock, including transactions to cover tax obligations related to vesting restricted stock units.

Summary

• James Mock, the Chief Financial Officer of Moderna, filed a Form 4 detailing changes in beneficial ownership of Moderna stock.
• On October 4, 2024, Mock acquired 1,453 shares through the vesting of restricted stock units (RSUs) and disposed of 10,220 shares.
• On October 7, 2024, Mock disposed of 715 shares at a price of $60.12 per share to cover tax withholding obligations related to the vesting of RSUs.
• Following these transactions, Mock beneficially owns 9,505 shares of Moderna common stock.
• Mock also holds 11,622 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, reflecting routine executive compensation activities.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like Moderna. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
• The 'sell to cover' mechanism impacts the company's equity incentive plans.

Key Dates